Cargando…

Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes

PURPOSE: For locoregionally recurrent head and neck squamous cell carcinoma (HNSCC), appropriate therapeutic decisions remain unclear. We examined the treatment outcomes of a national cohort to determine suitable treatments for and prognostic factors in patients with locoregionally recurrent HNSCCs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Jer-Hwa, Wu, Chia-Che, Yuan, Kevin Sheng-Po, Wu, Alexander T.H., Wu, Szu-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589686/ https://www.ncbi.nlm.nih.gov/pubmed/28903447 http://dx.doi.org/10.18632/oncotarget.16340

Ejemplares similares

Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma
por: Chen, Jin‐Hua, et al.
Publicado: (2016)

Predicting 90-Day Mortality in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma after Curative Surgery
por: Qin, Lei, et al.
Publicado: (2018)

Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma
por: Chen, Tien-Hua, et al.
Publicado: (2022)

Curative-Intent Aggressive Treatment Improves Survival in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma and High Comorbidity Index
por: Chen, Jin-Hua, et al.
Publicado: (2016)

Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer
por: Bruixola, Gema, et al.
Publicado: (2018)

Assessment and topographic characterization of locoregional recurrences in head and neck tumours
por: Ferreira, Brigida Costa, et al.
Publicado: (2015)

Comprehensive prognostic modeling of locoregional recurrence after radiotherapy for patients with locoregionally advanced hypopharyngeal squamous cell carcinoma
por: Liu, Hongjia, et al.
Publicado: (2023)

Dementia Risk in Irradiated Patients With Head and Neck Cancer
por: Chen, Jin-Hua, et al.
Publicado: (2015)

Salvage Carbon-Ion Radiation Therapy For Locoregionally Recurrent Head and Neck Malignancies
por: Gao, Jing, et al.
Publicado: (2019)

Impact of Treatment Modalities on Survival of Patients With Locoregional Esophageal Squamous-Cell Carcinoma in Taiwan
por: Chen, Hui-Shan, et al.
Publicado: (2016)

Prevalence of locoregional recurrence and survival post-treatment of head and neck cancers in Africa: a systematic review and meta-analysis
por: Melariri, Herbert, et al.
Publicado: (2023)

Prognosis Value of Platelet Counts, Albumin and Neutrophil-Lymphocyte Ratio of Locoregional Recurrence in Patients with Operable Head and Neck Squamous Cell Carcinoma
por: Ye, Jing, et al.
Publicado: (2020)

Anesthesia With Propofol Sedation Reduces Locoregional Recurrence in Patients With Breast Cancer Receiving Total Mastectomy Compared With Non-Propofol Anesthesia
por: Zhang, Jiaqiang, et al.
Publicado: (2022)

Persistent Post-radiotherapy Pain and Locoregional Recurrence in Head and Neck Cancer-Is There a Hidden Link?
por: Srivastava, Preety, et al.
Publicado: (2015)

High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent‐free survival in head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2019)

Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population
por: Chen, Wen-Chun, et al.
Publicado: (2017)

Efficacy of postoperative radiotherapy in patients with pathological stage N2 epidermal growth factor receptor wild type adenocarcinoma and squamous cell carcinoma lung cancer
por: Lin, Yen-Kuang, et al.
Publicado: (2016)

Gene expression analysis of head and neck squamous cell carcinoma survival and recurrence
por: Zhi, Xu, et al.
Publicado: (2014)

Phase 1/2a, open‐label, multicenter study of RM‐1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma
por: Cognetti, David M., et al.
Publicado: (2021)

Impact of submandibular gland preservation in neck management of early-stage buccal squamous cell carcinoma on locoregional control and disease-specific survival
por: Gu, Bo, et al.
Publicado: (2020)

Outcomes of Induction Chemotherapy for Head and Neck Cancer Patients: A Combined Study of Two National Cohorts in Taiwan
por: Chen, Jin-Hua, et al.
Publicado: (2016)

Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma
por: Li, Cheng, et al.
Publicado: (2020)

Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma
por: Liu, Baoling, et al.
Publicado: (2021)

Transcriptional Activity of Human Epidermal Growth Factor Receptor Family and Angiogenesis Effectors in Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma and Correlation with Patient Outcome
por: Pentheroudakis, George, et al.
Publicado: (2009)

Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Big and Intriguing Challenge Which May Be Resolved by Integrated Treatments Combining Locoregional and Systemic Therapies
por: Ionna, Franco, et al.
Publicado: (2021)

Concurrent Radiotherapy with Carboplatin and Cetuximab for the Treatment of Medically Compromised Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
por: Saigal, Kunal, et al.
Publicado: (2014)

The prognostic value of lymph node ratio in survival of head-and-neck squamous cell carcinoma
por: Eshraghi Samani, Reza, et al.
Publicado: (2018)

HPV-Related Prognostic Signature Predicts Survival in Head and Neck Squamous Cell Carcinoma
por: Zhao, Hongyu, et al.
Publicado: (2022)

MicroRNA-17-5p regulated apoptosis-related protein expression and radiosensitivity in oral squamous cell carcinoma caused by betel nut chewing
por: Wu, Szu-Yuan, et al.
Publicado: (2016)

Locoregional Control and Survival in Children, Adolescents, and Young Adults With Localized Head and Neck Alveolar Rhabdomyosarcoma—The French Experience
por: Machavoine, Roxane, et al.
Publicado: (2022)

Postmastectomy locoregional recurrence and recurrence-free survival in breast cancer patients
por: Kheradmand, Ali Arab, et al.
Publicado: (2010)

A Transcriptomic Analysis of Head and Neck Squamous Cell Carcinomas for Prognostic Indications
por: Chi, Li-Hsing, et al.
Publicado: (2021)

PLODs: Novel prognostic biomarkers and potential immunotherapy targets for head and neck squamous cell carcinoma
por: Gong, Siming, et al.
Publicado: (2023)

Quality of life analysis of patients treated with cetuximab or cisplatin for locoregionally advanced squamous cell carcinoma of head and neck in the United States
por: Aggarwal, Himani, et al.
Publicado: (2020)

Gross tumor volume is an independent prognostic factor in patients with postoperative locoregional recurrence of esophageal squamous cell carcinoma
por: Shi, Yu, et al.
Publicado: (2019)

Cutaneous Angiosarcoma of Head and Neck: A New Predictive Score for Locoregional Metastasis()()
por: Gründahl, J.E.H., et al.
Publicado: (2015)

Upregulation of SQLE Contributes to Poor Survival in Head and Neck Squamous Cell Carcinoma
por: Li, Jing, et al.
Publicado: (2022)

A prognostic index for locoregional recurrence after neoadjuvant chemotherapy
por: Herrero-Vicent, C, et al.
Publicado: (2016)

Development and validation of a RNA binding protein-associated prognostic model for head and neck squamous cell carcinoma
por: Yang, Xiuping, et al.
Publicado: (2021)

Prognostic Score Predicts Survival in HPV-Negative Head and Neck Squamous Cell Cancer Patients
por: Qian, Xu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bdqr1fs9spodi4dq5k4nuj6s21